Medicine prices, availability and affordability in Sri Lanka

Indian Journal of Pharmacology

Volumn 43, Issue 1, 2011, Pages 60-63

  Ganga Senarathna, S M D K ^a   Mannapperuma, Uthpali ^a   Rohini Fernandopulle, B M ^b  

^a Department of Pharmacology   (India)

^b University of Colombo   (India)

Author keywords

Affordability; availability; medicine prices; price control

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; AMOXICILLIN; ATENOLOL; CARBAMAZEPINE; CEFALEXIN; DIAZEPAM; ENALAPRIL; ERYTHROMYCIN; FUROSEMIDE; GENERIC DRUG; GLIBENCLAMIDE; MEBENDAZOLE; METFORMIN; OMEPRAZOLE; RANITIDINE; SALBUTAMOL;

ARTICLE; DIABETES MELLITUS; DRUG COST; DRUG MARKETING; EPILEPSY; HUMAN; HYPERTENSION; RESPIRATORY TRACT INFECTION; SOCIOECONOMICS; SRI LANKA; WORLD HEALTH ORGANIZATION;

EID: 78951472142     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.75672     Document Type: Article

References (13)

1. Central Bank of Sri Lanka. Annual Report 2003. Colombo: Central Bank of Sri Lanka; 2003. p. 268.
2. Balasubramaniam K, Jayasekara J. Affordability and Medicine's Prices in Sri Lanka. Paper presented at: Technical Sessions of the Pharmaceutical Society of Sri Lanka 2009. Proceedings of the 40 th PSSL Annual Sessions: Colombo, Sri Lanka; 2009.
3. World Health Organization, Health Action International. Medicines prices: A new approach to measurement. 1 st ed. Geneva: World Health Organization; 2003. p. 147.
4. Angell M. The Truth About the Drug Companies how they deceive us and what to do about it. 1 st ed. New York: Random House; 2004. p. 308.
5. Aaserud M, Austvoll-Dahlgren A, Ksters JP, Oxman AD, Ramsay C, Heidrun S. Pharmaceutical policies: Effects of reference pricing, other pricing, and purchasing policies. 2006 Apr 19. In: Cochrane Database Systemic Reviews [Internet]. Hoboken (NJ): John Wiley and Sons Ltd. c2009-. 426K. Available from: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005979/ frame.html Record No.: CD005979. [last amended on 2009 Jul 8] [last cited 14 Jul 2009].
6. Weerasuriya K, Amarasekeara N. List of Essential Drugs: Second Revision. Colombo: Ministry of Health Sri Lanka, Sponsored by the State Pharmaceuticals Manufacturing Corporation of Sri Lanka; 1999.
7. The international price indicator guide [Internet]. Massachusetts: Management Sciences for Health. Available from: http://erc.msh.org/mainpage.cfm? file=1.0.htmandmodule=Dmpandlanguage=English. [last cited on 2009 Feb 27].
8. Central Bank of Sri Lanka [Internet]. Colombo (LK): Central Bank of Sri Lanka. Available from: http://www.cbsl.gov.lk/. [last cited on 2003 Jul 1].
9. Central Bank of Sri Lanka. Colombo (LK): Central Bank of Sri Lanka. Available from: http://www.cbsl.gov.lk/. [last cited on 2006 Nov 1].
10. Central Bank of Sri Lanka. Colombo (LK): Central Bank of Sri Lanka. Available from: http://www.cbsl.gov.lk/. [last cited on 2009 Feb 27].
11. Gelders S, Ewen M, Noguchi N, Laing R. Price, availability and affordability: An international comparison of chronic disease medicines. Cairo: World Health Organization; 2006.
12. Babar ZU, Ibrahim MI, Singh H, Bukahri NI, Creese A. Evaluating drug prices, availability, affordability, and price components: Implications for access to drugs in malaysia. PLoS Med 2003;4:466-75.
13. Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, et al. Prices and availability of common medicines at six sites in India using a standard methodology. Indian J Med Res 2007;125:645-54.